Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14151 - 14175 of 14520 in total

GET-73

Get 73 has been investigated for the treatment of Alcohol Dependence.
Investigational

2,2-bis(4-hydroxy-3-tert-butylphenyl)propane

TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational

Viminol

Experimental

Cibenzoline

Experimental

Budipine

Experimental

Cloranolol

Experimental

Levomethadone

Experimental

Sequifenadine

Experimental

Picloxydine

Experimental

Sulbentine

Experimental

Xibornol

Experimental

Guanoclor

Experimental

Clofibride

Experimental

Hexamethonium

A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by...
Experimental
Matched Description: … It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. …

2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL

Experimental

Imiglitazar

Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational

MRX-I

MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational

N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide

Experimental

4-Acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2H-pyran-2-carboxylic acid

Experimental

N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE

Experimental

(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine

Experimental

N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide

Experimental

N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE

Experimental

5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID

Experimental

XMT-1001

XMT-1001 is a polymer-based prodrug of camptothecin (CPT), a well-characterized topoisomerase I inhibitor with potent anti-tumor activity. It is a water-soluble macromolecular conjugate of camptothecin (CPT). In this novel CPT pro-drug, CPT is conjugated with a 70 kDa biodegradable hydrophilic polyacetal, poly (1-hydroxymethylene hydroxylmethylformal). XMT-1001 has demonstrated an improved therapeutic...
Investigational
Matched Description: … XMT-1001 has demonstrated an improved therapeutic window as compared with CPT and irinotecan in human …
Displaying drugs 14151 - 14175 of 14520 in total